Delivery Order SPE2DB22D3004-SPE2DB25FRC86
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,009.98 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a hormone replacement therapy product. The contract was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, under firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,524.95 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal estrogen medication used in hormone replacement therapy. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,585.86 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,996.37 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.26 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal estradiol hormone replacement therapy product. Issued on September 26, 2025, with an ultimate completion date of September 29, 2025, this firm fixed-price delivery order represents a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,564.48 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price contract was competitively awarded without a set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The product being delivered is a transdermal estradiol patch used in hormone replacement therapy, consistent with AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,781.69 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Climara Pro Patch 4S, a transdermal hormone replacement therapy patch. This firm fixed-price delivery order, which is not set-aside designated, reflects a competitive award to the vendor and represents a single transaction under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a $1,009.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal estrogen medication. This non-set-aside competitive award was issued on May 8, 2025, with an ultimate completion date of May 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.44 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a hormone replacement therapy product. This non-set-aside, firm fixed price delivery order was competitively awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.12 to AmerisourceBergen Drug Corp for CLIMARA PRO PATCH 4S, a hormone replacement therapy product. This firm fixed-price, non-set-aside contract was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. The order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRC86Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,038.24 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal hormone replacement therapy medication. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs and the Defense Health Agency. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through competitive award processes, combined with its extensive portfolio of pharmaceutical product deliveries, positions it as a critical vendor within the federal medical supply chain for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/18/25 |